John J. Crowley

SVP, Chief Accounting Officer, Charles River Laboratories.

Companies

Centessa Pharmaceuticals plcChief financial officer Jun 17, 2024 to now¹
Fusion PharmaceuticalsChief financial officer Jun 25, 2020 to Jun 4, 2024²
Charles River LaboratoriesSVP, Chief Accounting Officer Oct 3, 2013 to Oct 4, 2016³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Fusion Pharmaceuticals FUSN0 shares⁴Jun 4, 2024
Centessa Pharmaceuticals plc0 shares⁵Jun 24, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 24, 2026Returned to company 45,000 shares of Centessa Pharmaceuticals plc⁵
Feb 2, 2026Granted 45,000 shares of Centessa Pharmaceuticals plc⁶
Jun 4, 2024Returned to company 10,410 shares of Fusion Pharmaceuticals⁴
Aug 31, 2021Granted 3,910 shares of Fusion Pharmaceuticals⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCentessa Pharmaceuticals plc, Chief financial officer
2
SEC EDGARFusion Pharmaceuticals, Chief financial officer
3
SEC EDGARCharles River Laboratories, SVP, Chief Accounting Officer
4
SEC EDGARFusion Pharmaceuticals shares after the filing of Jun 4, 2024
5
SEC EDGARCentessa Pharmaceuticals plc shares after the filing of Jun 24, 2026
6
SEC EDGARForm 4 filed Feb 3, 2026
7
SEC EDGARForm 4 filed Feb 3, 2022